# Neogenomics Inc: Form 8-K, filed Aug 11, 2026

- Company: [Neogenomics Inc](/companies/neo.md) (CIK 1077183)
- Form: 8-K
- Filed: 2026-08-11
- Accepted by EDGAR: Aug 11, 2026, 20:10 ET
- Period: 2026-08-07
- Accession: 0001628280-26-055697
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1077183/000162828026055697/neo-20260807.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1077183/000162828026055697/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1077183/000162828026055697/neo-20260807.htm

Filed Aug 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-055697. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.